发布求助
文献互助 智能选刊 最新文献

Trends in pharmacological sciences最新文献

筛选
英文 中文
How can quantum computing be applied in clinical trial design and optimization? 如何将量子计算应用于临床试验设计和优化？
IF 13.9 1区 医学
Trends in pharmacological sciences Pub Date : 2024-10-01 Epub Date: 2024-09-23 DOI: 10.1016/j.tips.2024.08.005
Hakan Doga, Aritra Bose, M Emre Sahin, Joao Bettencourt-Silva, Anh Pham, Eunyoung Kim, Alan Andress, Sudhir Saxena, Laxmi Parida, Jan Lukas Robertus, Hideaki Kawaguchi, Radwa Soliman, Daniel Blankenberg
{"title":"How can quantum computing be applied in clinical trial design and optimization?","authors":"Hakan Doga, Aritra Bose, M Emre Sahin, Joao Bettencourt-Silva, Anh Pham, Eunyoung Kim, Alan Andress, Sudhir Saxena, Laxmi Parida, Jan Lukas Robertus, Hideaki Kawaguchi, Radwa Soliman, Daniel Blankenberg","doi":"10.1016/j.tips.2024.08.005","DOIUrl":"10.1016/j.tips.2024.08.005","url":null,"abstract":"<p><p>Clinical trials are necessary for assessing the safety and efficacy of treatments. However, trial timelines are severely delayed with minimal success due to a multitude of factors, including imperfect trial site selection, cohort recruitment challenges, lack of efficacy, absence of reliable biomarkers, etc. Each of these factors possesses a unique computational challenge, such as data management, trial simulations, statistical analyses, and trial optimization. Recent advancements in quantum computing offer a promising opportunity to overcome these hurdles. In this opinion we uniquely explore the application of quantum optimization and quantum machine learning (QML) to the design and execution of clinical trials. We examine the current capabilities and limitations of quantum computing and outline its potential to streamline clinical trials.</p>","PeriodicalId":23250,"journal":{"name":"Trends in pharmacological sciences","volume":" ","pages":"880-891"},"PeriodicalIF":13.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142354508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neurofilament light chain as a biomarker of chemotherapy-induced peripheral neuropathy. 作为化疗诱发周围神经病变生物标志物的神经丝蛋白轻链
IF 13.9 1区 医学
Trends in pharmacological sciences Pub Date : 2024-10-01 Epub Date: 2024-09-05 DOI: 10.1016/j.tips.2024.08.001
Nanna E Andersen, Wolfgang Boehmerle, Petra Huehnchen, Tore B Stage
{"title":"Neurofilament light chain as a biomarker of chemotherapy-induced peripheral neuropathy.","authors":"Nanna E Andersen, Wolfgang Boehmerle, Petra Huehnchen, Tore B Stage","doi":"10.1016/j.tips.2024.08.001","DOIUrl":"10.1016/j.tips.2024.08.001","url":null,"abstract":"<p><p>Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of chemotherapy. The frequency of CIPN ranges from one in three to almost all patients depending on type of chemotherapy and dose. It causes symptoms that can range from sensitivity to touch and numbness to neuropathic pain in hands and feet. CIPN is notoriously difficult to grade objectively and has mostly relied on a clinician- or patient-based rating that is subjective and poorly reproducible. Thus, considerable effort has been aimed at identifying objective biomarkers of CIPN. Recent in vitro, animal, and clinical studies suggest that neurofilament light chain (NFL), a structural neuronal protein, may be an objective biomarker of CIPN. NFL released from cells to cell culture media reflects in vitro neurotoxicity, while NFL in serum reflects neuronal damage caused by chemotherapy in rodent models. Finally, NFL in serum may be a diagnostic biomarker of CIPN, but its prognostic ability to predict CIPN requires prospective evaluation. We discuss current limitations and future perspectives on the use of NFL as a preclinical and clinical biomarker of CIPN.</p>","PeriodicalId":23250,"journal":{"name":"Trends in pharmacological sciences","volume":" ","pages":"872-879"},"PeriodicalIF":13.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142146303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting TRPM channels for cerebral ischemia-reperfusion injury. 针对脑缺血再灌注损伤的 TRPM 通道。
IF 13.9 1区 医学
Trends in pharmacological sciences Pub Date : 2024-10-01 Epub Date: 2024-07-16 DOI: 10.1016/j.tips.2024.06.005
Dai-Qiang Liu, Wei Mei, Ya-Qun Zhou, Hong Xi
{"title":"Targeting TRPM channels for cerebral ischemia-reperfusion injury.","authors":"Dai-Qiang Liu, Wei Mei, Ya-Qun Zhou, Hong Xi","doi":"10.1016/j.tips.2024.06.005","DOIUrl":"10.1016/j.tips.2024.06.005","url":null,"abstract":"<p><p>Transient receptor potential melastatin (TRPM) channels have emerged as potential therapeutic targets for cerebral ischemia-reperfusion (I/R) injury. We highlight recent findings on the involvement of TRPM channels in oxidative stress, mitochondrial dysfunction, inflammation, and calcium overload. We also discuss the challenges and future directions in targeting TRPM channels for cerebral I/R injury.</p>","PeriodicalId":23250,"journal":{"name":"Trends in pharmacological sciences","volume":" ","pages":"862-867"},"PeriodicalIF":13.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141634629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spare the pain for your gut Treg cells! 让你的肠道 Treg 细胞免受痛苦！
IF 13.9 1区 医学
Trends in pharmacological sciences Pub Date : 2024-10-01 Epub Date: 2024-09-05 DOI: 10.1016/j.tips.2024.08.008
Manon Defaye, Christophe Altier
{"title":"Spare the pain for your gut Treg cells!","authors":"Manon Defaye, Christophe Altier","doi":"10.1016/j.tips.2024.08.008","DOIUrl":"10.1016/j.tips.2024.08.008","url":null,"abstract":"<p><p>Maintaining gut homeostasis requires a complex interplay between the nervous and immune systems and the microbiome, but the nature of their interactions remains unclear. Chiu and Benoist's teams employed designer receptors exclusively activated by designer drugs (DREADD)-based chemogenetics to target specific neuronal cell types and evaluate their effects on both the gut immune system and the microbiota.</p>","PeriodicalId":23250,"journal":{"name":"Trends in pharmacological sciences","volume":" ","pages":"859-861"},"PeriodicalIF":13.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142146304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metabolic regulation in normal and leukemic stem cells 正常干细胞和白血病干细胞的代谢调节
IF 13.8 1区 医学
Trends in pharmacological sciences Pub Date : 2024-09-20 DOI: 10.1016/j.tips.2024.08.004
Cheuk-Him Man, Changzheng Li, Xi Xu, Meng Zhao
{"title":"Metabolic regulation in normal and leukemic stem cells","authors":"Cheuk-Him Man, Changzheng Li, Xi Xu, Meng Zhao","doi":"10.1016/j.tips.2024.08.004","DOIUrl":"https://doi.org/10.1016/j.tips.2024.08.004","url":null,"abstract":"<p>Hematopoietic stem cells (HSCs) and leukemic stem cells (LSCs) are crucial for ensuring hematopoietic homeostasis and driving leukemia progression, respectively. Recent research has revealed that metabolic adaptations significantly regulate the function and survival of these stem cells. In this review, we provide an overview of how metabolic pathways regulate oxidative and proteostatic stresses in HSCs during homeostasis and aging. Furthermore, we highlight targetable metabolic pathways and explore their interactions with epigenetics and the microenvironment in addressing the chemoresistance and immune evasion capacities of LSCs. The metabolic differences between HSCs and LSCs have profound implications for therapeutic strategies.</p>","PeriodicalId":23250,"journal":{"name":"Trends in pharmacological sciences","volume":"13 1","pages":""},"PeriodicalIF":13.8,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142264601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rezdiffra™ (resmetirom): a THR-β agonist for non-alcoholic steatohepatitis Rezdiffra™（resmetirom）：治疗非酒精性脂肪性肝炎的 THR-β 激动剂
IF 13.8 1区 医学
Trends in pharmacological sciences Pub Date : 2024-09-19 DOI: 10.1016/j.tips.2024.08.009
Niki F. Brisnovali, Connor Haney, Leigh Goedeke
{"title":"Rezdiffra™ (resmetirom): a THR-β agonist for non-alcoholic steatohepatitis","authors":"Niki F. Brisnovali, Connor Haney, Leigh Goedeke","doi":"10.1016/j.tips.2024.08.009","DOIUrl":"https://doi.org/10.1016/j.tips.2024.08.009","url":null,"abstract":"No Abstract","PeriodicalId":23250,"journal":{"name":"Trends in pharmacological sciences","volume":"26 1","pages":""},"PeriodicalIF":13.8,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142264600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Engineering extracellular vesicles for diagnosis and therapy 细胞外囊泡工程用于诊断和治疗
IF 13.8 1区 医学
Trends in pharmacological sciences Pub Date : 2024-09-19 DOI: 10.1016/j.tips.2024.08.007
Zhengyue Fei, Jiamin Zheng, Xiangxiang Zheng, Hao Ren, Guannan Liu
{"title":"Engineering extracellular vesicles for diagnosis and therapy","authors":"Zhengyue Fei, Jiamin Zheng, Xiangxiang Zheng, Hao Ren, Guannan Liu","doi":"10.1016/j.tips.2024.08.007","DOIUrl":"https://doi.org/10.1016/j.tips.2024.08.007","url":null,"abstract":"<p>Extracellular vesicle (EV)-based therapeutics have gained substantial interest in the areas of drug delivery, immunotherapy, and regenerative medicine. However, the clinical translation of EVs has been slowed due to limited yields and functional heterogeneity, as well as inadequate targeting. Engineering EVs to modify their inherent function and endow them with additional functions has the potential to advance the clinical translation of EV applications. Bio-orthogonal click chemistry is an engineering approach that modifies EVs in a controlled, specific, and targeted way without compromising their intrinsic structure. Here, we provide an overview of bio-orthogonal labeling approaches involved in EV engineering. We also present the isolation methods of bio-orthogonally labeled vesicles using magnetic beads, microfluidics, and microarray chip technologies. We highlight the <em>in vivo</em> applications of bio-orthogonal labeling EVs for diagnosis and therapy, especially the exciting potential of bio-orthogonal glycometabolic engineered EVs for targeted therapies.</p>","PeriodicalId":23250,"journal":{"name":"Trends in pharmacological sciences","volume":"210 1","pages":""},"PeriodicalIF":13.8,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142269466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments 溃疡性结肠炎：临床生物标记物、治疗目标和新兴疗法
IF 13.8 1区 医学
Trends in pharmacological sciences Pub Date : 2024-09-10 DOI: 10.1016/j.tips.2024.08.003
Phurpa Wangchuk, Karma Yeshi, Alex Loukas
{"title":"Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments","authors":"Phurpa Wangchuk, Karma Yeshi, Alex Loukas","doi":"10.1016/j.tips.2024.08.003","DOIUrl":"https://doi.org/10.1016/j.tips.2024.08.003","url":null,"abstract":"<p>Ulcerative colitis (UC) is one of the two forms of inflammatory bowel disease. It affects 5 million people globally, and is a chronic and recurring inflammation of the gastrointestinal tract with clinical presentation of abdominal pain, chronic diarrhea, rectal bleeding, and weight loss. The cause and the etiology of UC remain poorly understood. There is no cure and no ‘gold standard diagnostic’ for UC. The existing treatments are ineffective, and UC patients have a lower life expectancy with a risk of colorectal cancer. Recent studies in pathophysiology, clinical presentation, and biomarkers have significantly improved our understanding of UC. In this review we summarize recent advances in identifying novel clinical biomarkers, diagnostics, treatment targets, and emerging therapeutics. These insights are expected to assist in developing effective treatments for UC.</p>","PeriodicalId":23250,"journal":{"name":"Trends in pharmacological sciences","volume":"12 1","pages":""},"PeriodicalIF":13.8,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142203097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ensifentrine (Ohtuvayre™) for chronic obstructive pulmonary disease 治疗慢性阻塞性肺病的 Ensifentrine (Ohtuvayre™)
IF 13.8 1区 医学
Trends in pharmacological sciences Pub Date : 2024-09-10 DOI: 10.1016/j.tips.2024.08.002
Sandra Hubert, Ayrin Kök-Carrière, Frédéric De Ceuninck
{"title":"Ensifentrine (Ohtuvayre™) for chronic obstructive pulmonary disease","authors":"Sandra Hubert, Ayrin Kök-Carrière, Frédéric De Ceuninck","doi":"10.1016/j.tips.2024.08.002","DOIUrl":"https://doi.org/10.1016/j.tips.2024.08.002","url":null,"abstract":"No Abstract","PeriodicalId":23250,"journal":{"name":"Trends in pharmacological sciences","volume":"20 1","pages":""},"PeriodicalIF":13.8,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142203094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Subscription and Copyright Information 订阅和版权信息
IF 13.8 1区 医学
Trends in pharmacological sciences Pub Date : 2024-09-05 DOI: 10.1016/s0165-6147(24)00175-5
{"title":"Subscription and Copyright Information","authors":"","doi":"10.1016/s0165-6147(24)00175-5","DOIUrl":"https://doi.org/10.1016/s0165-6147(24)00175-5","url":null,"abstract":"No Abstract","PeriodicalId":23250,"journal":{"name":"Trends in pharmacological sciences","volume":"20 1","pages":""},"PeriodicalIF":13.8,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142203099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信